Managers
A subsidiary of Ares Management Corporation (Ares) (NYSE: ARES) has has entered into a definitive agreement with a subsidiary of BrightSphere Investment Group Inc (NYSE: BSIG) and Landmark Investment Holdings LP to acquire 100 per cent of Landmark Partners, LLC (collectively with its subsidiaries, Landmark), one of the largest and most experienced investors in acquiring secondary private fund ownership stakes in the alternative asset management industry.
The transaction is valued at USD1.08 billion, including approximately USD787 million in cash and approximately USD293 million in Ares Operating Group Units, in each case subject to certain adjustments.
With 150 employees
Medtanken, a leading primary care group in Western Sweden and a portfolio company of Procuritas Capital Investors VI (Procuritas), has successfully executed a bolt-on acquisition of Kvarterskliniken to further expand the group.
This acquisition comes soon after Procuritas invested in and partnered with Medtanken, which was formed through the recent merger of Medpro and Omtanken.
Medtanken has a vision of delivering and enhancing quality primary care provision in Sweden and to develop digi-physical solutions which will increase accessibility and patient satisfaction.
With its passion for building strong sustainable businesses through transformational growth, Procuritas partnered with Medtanken to facilitate
Baseimmune, an early-stage UK biotech startup, is combining big data and biological expertise to predict how viruses will change and identify ‘future-proof’ antigens that will form the crucial elements of the next generation of vaccines.
In order to further the development of its platform and start pre-clinical development in the lab, Baseimmune has secured a GBP685,000 investment, led by European university VC fund, Creator Fund, and includes Mike Watson, ex-president of Moderna’s infectious disease spin-out with the support of Vaccitech and Oxford University. Maki VC and Rockmount Seed Investments also joined the round.
Baseimmune’s technology delivers plasticity into these vaccines
Tees Valley based cleantech company Nova Pangaea Technologies (Nova Pangaea) has experienced significant growth as a result of its two funding rounds with the Northern Powerhouse Investment Fund (NPIF), including a 45 per cent increase in staff numbers since January 2020.
The company, which has invested in a number of senior recruits in recent months, taking its total full-time members of staff to 17, has also secured a string of plant trials with large forestry, agriculture and oil and gas multinationals. It has also secured a large engineering project in Pakistan and is set to enter the US and Canadian
GP Bullhound has made a follow-on investment in Glovo, one of the world’s leading multi-category delivery players, as part of a Series F funding round of EUR450 million (USD530 million) led by Luxor Capital Group, with participation from existing investors including Delivery Hero and Drake Enterprises.
Founded in Barcelona in 2015, Glovo is a pioneering multi-category delivery app and one of the world’s leading delivery platforms. It operates in Southern Europe and EEMEA, connecting users with restaurants, grocery chains, pharmacies and retail stores.
Following this latest funding round, the largest in history for a Spanish startup, Glovo will invest
Healthcare start-up Béa Fertility has raised GBP800,000 (USD1 million) to bring an innovative at-home fertility treatment to the UK. The round was led by Calm/Storm VC and joined by Q Ventures, and includes an innovation grant from the recent InnovateUK SMART competition.
Founded by embryologist David O’Rourke and femtech specialist Tess Cosad, Béa Fertility is focused on democratising access to affordable, effective fertility treatments for couples and individuals who are struggling to conceive. It is estimated that infertility affects one in seven heterosexual couples in the UK.
Currently, the next step for those who are unable to conceive naturally
Aquila European Renewables Income Fund (AERIF), a London-listed investment company advised by Aquila Capital Investmentgesellschaft mbh, has entered into a Sale and Purchase Agreement (SPA) to acquire 50 per cent of the equity in an unlevered Portuguese solar operating asset (Ourique).
Closing of the transaction is expected to occur in April 2021.
Ourique is located in Alentejo, Portugal, and has an installed capacity of c60 MWp. The solar farm started its operations in December 2019 and its power price hedges cover 100 per cent of the produced energy until March 2026.
Ourique will save approximately 17,035 tons of CO2 emissions
Wellbeam Consumer Health, formerly Yukon Wellness Holdings, has acquired Penetrex, a leading joint & muscle relief and recovery brand. Penetrex is Wellbeam Consumer Health’s second acquisition in the ecommerce-focused wellness brands space. Eu Natural, a fast-growing, digitally-native provider of vitamin and mineral nutritional supplement products, was acquired in January 2021.
Wellbeam Consumer Health, an American Pacific Group portfolio company, is led by Chris Marschall, who was appointed as CEO in February 2021 to build out and expand the business. Wellbeam Consumer Health’s goal is to be the leading ecommerce-based consumer wellness business and is actively seeking to grow its portfolio
Hayfin Capital Management (Hayfin) has announced a record period of deployment through its Direct Lending strategy, having invested EUR3.7 billion in 2020.
Hayfin reached a final close on the commingled Hayfin Direct Lending Fund III and its related separately managed accounts in 2020, raising in excess of EUR5 billion to deploy into performing loans to European middle-market companies. During this record period of activity, the firm bolstered its investment team, business development function and back-office operations with 35 new hires.
Within its Direct Lending strategy, Hayfin focuses on the provision of senior-secured loans that exhibit strong returns relative to
Francisco Partners, a global investment firm that specialises in partnering with technology businesses, is to acquire BARBRI Inc (BARBRI) from Leeds Equity Partners (Leeds Equity). Terms of the transaction have not been announced.
BARBRI is specialist in technology-enabled legal education, offering a comprehensive product suite across the complete legal education lifecycle. For decades, BARBRI has helped tens of thousands of test takers each year prepare for and pass the Bar exam. More recently, BARBRI has leveraged its technology platform to develop test preparation offerings in the UK with the SQE, in professional education with Paralegal and eDiscovery certification, and in
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
